Menu
Demetra Lifecare, an important holding company, based in Milan, focused on managing and developing healthcare facilities, research institutes, laboratories, and rehabilitation centers, collaborates with Polo GGB regarding diagnostic services.
Polo GGB collaborates with U-ANT for the management of pandemic events such as the COVID-19 pandemic. By applying Artificial Intelligence algorithms and Machine Learning to genomics and molecular biology, U-ANT provides medium and large companies with the ACORP+ platform. This platform assists in monitoring the risk of contagion among employees, identifying individuals at higher risk of contagion, thus providing a real-time map of epidemiological risk capable of offering the necessary information for implementing timely safety measures.
Netgenomics, an innovative start-up, collaborates with the laboratories of Polo GGB, which, utilizing next-generation sequencing (NGS) technologies, analyze DNA sequences to translate genetic code into useful information for improving one’s lifestyle and adapting it to individual characteristics.
BIOCENTIS is a biotechnology company bio-incubated at Polo GGB, focused on developing innovative and groundbreaking genetic solutions for the safe and effective control of the most dangerous insects responsible for spreading epidemic diseases and contributing significantly to the reduction of biodiversity and food security. Biocentis employs gene-drive and CRISPR technologies for a healthier and more sustainable world.
Dr. Orrico is a Medical Geneticist who practiced from 1992 to 2022 at the Azienda Ospedaliera Universitaria Senese, and from 2009 to 2021 served as the head of the Clinical Genetics service at the Misericordia Hospital in Grosseto. Dr. Orrico offers consultations and specialist visits in all areas related to possible genetically determined conditions or predispositions: oncology, rare diseases, infertility and assisted reproduction, prenatal risks.
Clicca sul contatto per iniziare una chat con noi.
